血清素是GLP-2的下游效应剂,增强乳腺收缩性和淋巴流
Lili Tian1,2, Majid Mufaqam Syed-Abdul1,2, Gary F Lewis1,2
1Division of Endocrinology, Department of Medicine, Banting & Best Diabetes Centre, University of Toronto, Toronto, Ontario, Canada.
类似葡萄糖-2 (GLP-2) 通过神经递质血清来调动肠道脂质,这种神经递质可以增强淋巴流和乳腺收缩性. 血管内皮生长因子受体3 (VEGFR3) 在这个过程中作用于血清素的下游.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 神经科学是一个神经科学.
背景情况:
- 类似葡萄糖-2 (GLP-2) 通过释放神经递质产生生物效应.
- 肠道神经系统 (ENS) 对于GLP-2诱导的脂质调动至关重要.
- 血清素和血管内皮生长因子受体3 (VEGFR3) 是潜在的媒介.
研究的目的:
- 确定神经递质中介GLP-2对肠道脂质调动的影响.
- 研究VEGFR3在GLP-2信号级联中的作用.
- 阐明GLP-2诱导的脂质运输机制.
主要方法:
- 鼠标淋巴的模型与内脂球体.
- 内注射GLP-2,血清素,受体对抗剂和VEGFR3抑制剂.
- 评估淋巴流量,甘油三产量,血血水平和乳腺收缩性.
主要成果:
- GLP-2的使用增加了血中血清激素度.
- 血清素增强了淋巴流动,淋巴甘油三糖体输出和乳腺收缩性.
- 血清素受体对抗性减少了GLP-2介导的作用;VEGFR3抑制消除了血清素诱导的作用.
结论:
- 氨酸调解GLP-2诱导的肠道脂质调动.
- GLP-2通过血激素增强淋巴流和乳腺收缩性.
- 在这个信号通路中,VEGFR3是血清素的下游目标.
更多相关视频
09:16Mixed Primary Cultures of Murine Small Intestine Intended for the Study of Gut Hormone Secretion and Live Cell Imaging of Enteroendocrine Cells
Published on: April 20, 2017
11:27Methods to Study Epithelial Transport Protein Function and Expression in Native Intestine and Caco-2 Cells Grown in 3D
Published on: March 16, 2017
相关概念视频
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Intestinal Phase of Digestion
The arrival of the chyme in the small intestine distends the duodenum, which triggers the enterogastric reflex. This distension...
Renewal of Intestinal Stem Cells
Pleiotropy
Hormonal Regulation
